🔎 Trials Near Me

Domov › Mieloproliferativni neoplazmi › Florida

Klinične študije za Mieloproliferativni neoplazmi v Florida

13 študij za Mieloproliferativni neoplazmi išče udeležence na lokacijah v Florida.

Mesta v Florida

Uradno besedilo študije (angleško)

A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms

  • BRCR Global - Coral Springs, Coral Springs
  • Moffitt Cancer Center, Tampa
Vključevanje udeležencevFaza 1
Starost 18 in več · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT07469891

A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)

  • UM Sylvester Comprehensive Cancer Center at Coral Gables, Coral Gables
  • UM Sylvester Comprehensive Cancer Center at Coral Springs, Coral Springs
  • UM Sylvester Comprehensive Cancer Center at Deerfield Beach, Deerfield Beach
  • in še 7
Vključevanje udeležencevFaza 2
Starost 18 in več · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT06661915

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

  • UF Health Cancer Institute - Gainesville, Gainesville
  • Mayo Clinic in Florida, Jacksonville
  • Miami Cancer Institute, Miami
  • in še 2
Vključevanje udeležencevFaza 2
Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT05564390

Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia

  • Mayo Clinic Jacksonville, Jacksonville
  • Sylvester Cancer Center - U Miami, Miami
  • Moffitt Cancer Center, Tampa
Vključevanje udeležencevFaza 1/2
Starost 18 in več · Vsi spoli · Posodobljeno 23. sep. 2026 · NCT05320198

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

  • Mayo Clinic in Florida, Jacksonville
  • Miami Cancer Institute, Miami
  • Memorial Hospital West, Pembroke Pines
Vključevanje udeležencevFaza 2
Starost 18–59 · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT05554406

Project: Every Child for Younger Patients With Cancer

  • Broward Health Medical Center, Fort Lauderdale
  • Golisano Children's Hospital of Southwest Florida, Fort Myers
  • UF Health Cancer Institute - Gainesville, Gainesville
  • in še 13
Vključevanje udeležencevOpazovalna študija
Do 25 let · Vsi spoli · Posodobljeno 25. avg. 2026 · NCT02402244

A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms

  • Mayo Clinic-Florida, Jacksonville
Vključevanje udeležencevFaza 1
Starost 18 in več · Vsi spoli · Posodobljeno 6. avg. 2026 · NCT07008118

Study of INCA036978 in Participants With Myeloproliferative Neoplasms

  • University of Miami, Miami
  • Moffitt Cancer Center, Tampa
Vključevanje udeležencevFaza 1
Starost 18 in več · Vsi spoli · Posodobljeno 22. jul. 2026 · NCT07441694

A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms

  • University of Miami Health System, Miami
Vključevanje udeležencevFaza 1
Starost 18 in več · Vsi spoli · Posodobljeno 17. apr. 2026 · NCT06034002

Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)

  • Moffitt Cancer Center, Tampa
Vključevanje udeležencevFaza 2
Starost 1–60 · Vsi spoli · Posodobljeno 12. mar. 2026 · NCT03970096

Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care

  • Sylvester Comprehensive Cancer Center, Miami
Vključevanje udeležencev
Starost 18 in več · Vsi spoli · Posodobljeno 20. feb. 2026 · NCT05745285

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Jacksonville
  • Massive Bio SYNERGY-AI site, Miami
  • Massive Bio SYNERGY-AI site, Tampa
Vključevanje udeležencevOpazovalna študija
Vse starosti · Vsi spoli · Posodobljeno 28. okt. 2025 · NCT03452774

Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.